Hemovent Overview
- Founded
- 2013

- Status
- Private
- Employees
- 16

- Latest Deal Type
- Series B
- Latest Deal Amount
- $10.7M

- Investors
- 11
Hemovent General Information
Description
Developer of a medical device designed to support or replace heart and lung functions in the event of cardiac or respiratory failure. The company's device provides respiratory support to patients whose lungs are so damaged that they cannot perform their basic functions or acts as a temporary life support system and takes over the hearts function in case of acute heart failure, providing hospitals with enough time to address the underlying problems that caused the failure.
Contact Information
- Pascalstraße 59
- 52076 Aachen
- Germany
Hemovent Timeline
Hemovent Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC (Series B) | 07-Jul-2020 | $10.7M | 000.00 | 000.00 | Completed | Generating Revenue |
4. Accelerator/Incubator | 000.00 | Completed | Generating Revenue | |||
3. Early Stage VC (Series A) | 25-Jul-2017 | 00.00 | 000.00 | 000.00 | Completed | Generating Revenue |
2. Grant | 24-Apr-2017 | $810K | $6M | Completed | Generating Revenue | |
1. Early Stage VC (Series A) | 10-Feb-2016 | $6M | $6M | 000.00 | Completed | Generating Revenue |
Hemovent Comparisons
Industry
00000
000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialHemovent Competitors (7)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
ALung | Venture Capital-Backed | Pittsburgh, PA | 00 | 00000 | 00000000000 | 00000 |
000000 | Formerly VC-backed | Heilbronn, Germany | 000 | 000000&0 | ||
000000000 | Corporation | Minneapolis, MN | 00000 | 00000000 | ||
0000000 | Corporation | Danvers, MA | 0000 | 000.00 | 00000000000 | 000.00 |
00000000 | Formerly VC-backed | London, United Kingdom | 0000 | 000.00 | 000000000 | 000.00 |
Hemovent Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Christof Lenz | Co-Founder and Chief Executive Officer | ||
Oliver Marseille Ph.D | Co-Founder & Chief Technology Officer |
Hemovent Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Matthias Guth | MIG AG | Board Member | 000 0000 |
Hemovent Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialHemovent Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Government of Germany | Government | 000 0000 | 000000 0 | ||
First Capital Partner | Venture Capital | Minority | 000 0000 | 000000 0 | |
KfW Group | Investment Bank | Minority | 000 0000 | 000000 0 | |
MIG AG | Venture Capital | Minority | 000 0000 | 000000 0 | |
NRW.Bank | Investment Bank | Minority | 000 0000 | 000000 0 |